GGHC
RVNC
Gilder Gagnon Howe & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-57,123
| Closed | -$1.45M | – | 315 |
|
|
2023
Q2 | $1.45M | Buy |
57,123
+1,606
| +3% | +$40.6K | 0.02% | 213 |
|
|
2023
Q1 | $1.79M | Buy |
55,517
+2,578
| +5% | +$83K | 0.03% | 177 |
|
|
2022
Q4 | $977K | Sell |
52,939
-3
| -0% | -$55 | 0.02% | 198 |
|
|
2022
Q3 | $1.43M | Buy |
+52,942
| New | +$1.43M | 0.02% | 186 |
|